American Century Companies’s Medifast MED Stock Holding History

American Century Companies’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.29M	Buy	224,280 +6,458	+3%	+$69.6K	﹤0.01%	2074
2025 Q4	$2.33M	Sell	217,822 -3,423	-2%	-$41K	﹤0.01%	2037
2025 Q3	$3.02M	Buy	221,245 +7,274	+3%	+$102K	﹤0.01%	1912
2025 Q2	$3.01M	Sell	213,971 -10,974	-5%	-$144K	﹤0.01%	1880
2025 Q1	$3.03M	Sell	224,945 -19,240	-8%	-$289K	﹤0.01%	1818
2024 Q4	$4.3M	Buy	244,185 +8,058	+3%	+$150K	﹤0.01%	1663
2024 Q3	$4.52M	Buy	236,127 +37,389	+19%	+$720K	﹤0.01%	1632
2024 Q2	$4.34M	Buy	198,738 +29,476	+17%	+$786K	﹤0.01%	1561
2024 Q1	$6.49M	Buy	169,262 +29,396	+21%	+$1.42M	﹤0.01%	1373
2023 Q4	$9.4M	Buy	139,866 +75,105	+116%	+$5.23M	0.01%	1173
2023 Q3	$4.85M	Buy	64,761 +49,605	+327%	+$4.4M	﹤0.01%	1352
2023 Q2	$1.4M	Buy	15,156 +9,127	+151%	+$813K	﹤0.01%	1799
2023 Q1	$595K	Buy	6,029 +991	+20%	+$110K	﹤0.01%	2066
2022 Q4	$581K	Buy	5,038 +606	+14%	+$70.6K	﹤0.01%	2000
2022 Q3	$480K	Sell	4,432 -165,593	-97%	-$23.7M	﹤0.01%	1968
2022 Q2	$30.7M	Buy	170,025 +106,840	+169%	+$19.1M	0.03%	542
2022 Q1	$10.8M	Buy	63,185 +60,565	+2,312%	+$11.4M	0.01%	894
2021 Q4	$549K	Sell	2,620 -1,456	-36%	-$301K	﹤0.01%	1883
2021 Q3	$785K	Sell	4,076 -269	-6%	-$66.1K	﹤0.01%	1707
2021 Q2	$1.23M	Sell	4,345 -7,452	-63%	-$2.02M	﹤0.01%	1454
2021 Q1	$2.5M	Buy	11,797 +1,409	+14%	+$337K	﹤0.01%	1100
2020 Q4	$2.04M	Sell	10,388 -681	-6%	-$120K	﹤0.01%	1074
2020 Q3	$1.82M	Sell	11,069 -370	-3%	-$60.9K	﹤0.01%	997
2020 Q2	$1.59M	Sell	11,439 -7,431	-39%	-$682K	﹤0.01%	969
2020 Q1	$1.18M	Buy	+18,870	New	+$1.72M	﹤0.01%	958
2019 Q4	–	Sell	-123,935	Closed	-$12.8M	–	1533
2019 Q3	$12.8M	Sell	123,935 -31,118	-20%	-$3.34M	0.01%	565
2019 Q2	$19.9M	Sell	155,053 -29,502	-16%	-$4.1M	0.02%	504
2019 Q1	$23.5M	Buy	184,555 +46,115	+33%	+$5.85M	0.02%	469
2018 Q4	$17.3M	Buy	138,440 +2,663	+2%	+$456K	0.02%	494
2018 Q3	$30.1M	Sell	135,777 -9,401	-6%	-$1.91M	0.03%	439
2018 Q2	$23.3M	Sell	145,178 -73,923	-34%	-$9.45M	0.02%	491
2018 Q1	$20.5M	Sell	219,101 -74,672	-25%	-$5.58M	0.02%	503
2017 Q4	$20.5M	Sell	293,773 -7,342	-2%	-$487K	0.02%	510
2017 Q3	$17.9M	Buy	301,115 +113,885	+61%	+$5.67M	0.02%	549
2017 Q2	$7.76M	Buy	187,230 +42,710	+30%	+$1.86M	0.01%	734
2017 Q1	$6.41M	Buy	144,520 +5,256	+4%	+$226K	0.01%	804
2016 Q4	$5.8M	Sell	139,264 -4,578	-3%	-$184K	0.01%	825
2016 Q3	$5.44M	Buy	143,842 +7,129	+5%	+$256K	0.01%	849
2016 Q2	$4.55M	Sell	136,713 -2,071	-1%	-$66.8K	0.01%	866
2016 Q1	$4.19M	Buy	138,784 +117,907	+565%	+$3.45M	﹤0.01%	866
2015 Q4	$634K	Buy	+20,877	New	+$622K	﹤0.01%	1170
2014 Q4	–	Sell	-61,930	Closed	-$2.03M	–	1439
2014 Q3	$2.03M	Sell	61,930 -134,793	-69%	-$4.14M	﹤0.01%	1073
2014 Q2	$5.98M	Buy	196,723 +40,887	+26%	+$1.27M	0.01%	835
2014 Q1	$4.53M	Buy	155,836 +25,075	+19%	+$672K	0.01%	940
2013 Q4	$3.42M	Sell	130,761 -40,331	-24%	-$1.03M	﹤0.01%	1009
2013 Q3	$4.6M	Buy	171,092 +13,518	+9%	+$362K	0.01%	906
2013 Q2	$4.06M	Buy	+157,574	New	+$4.14M	0.01%	897

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

American Century Companies's MED Position: Q1 2026 in Review

American Century Companies increased its Medifast (MED) stake by 3% in Q1 2026, buying an estimated $69.6K and bringing the position to 224,280 shares worth $2.29M. The position accounts for ﹤0.01% of the portfolio, ranked #2074.

American Century Companies first reported a position in MED in Q2 2013 and has held it in 47 quarters since. The position peaked at $30.7M in Q2 2022. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.

American Century Companies held 224,280 shares of Medifast worth $2.29M as of Q1 2026.
American Century Companies bought 6,458 Medifast shares in Q1 2026, an estimated $69.6K.
Medifast made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2074 holding.
American Century Companies first reported a position in Medifast in Q2 2013 and has held it in 47 quarters since.
American Century Companies's Medifast position peaked at $30.7M in Q2 2022.
111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.